🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07361627
Starting soon Not applicable

Upper Limb Rehabilitation Using Non-invasive Spinal Cord Stimulation

NCT07361627 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-09-01
Last updated
2026-07-28

Condition(s) studied

Spinal Cord Injury CervicalSpinal Cord Injury, AcuteSpinal Cord Injury (Quadraplegia)

Investigational drug(s) / intervention(s)

Protocol 1: Combination of activity-based therapy and sham spinal cord stimulationProtocol 2: Combination of activity-based therapy and facilitatory transcutaneous spinal cord stimulation

Protocol 1: Combination of activity-based therapy and sham spinal cord stimulation: The training session for the sham group comprises of activity-based therapy along with sham stimulation on the spinal cord of the participants. These training sessions will include repetitive, intensive strength training and functional exercises targeting arm and hand (upper limb) movements. Sessions will be delivered by trained physiotherapists and occupational therapists. Each participant will complete 20 sessions over six to eight weeks (three per week), with each session lasting 45 minutes. Breaks will be added, if needed. Training will consist of cardiovascular training, stretching, weight-bearing, strengthening and controlled strengthening and task-oriented training. Participants will receive transcutaneous spinal cord stimulation set at sensory threshold intensity (i.e., below the threshold that facilitates voluntary movement of the limb; usually 2-3 mA intensity), delivered simultaneously with training.

Protocol 2: Combination of activity-based therapy and facilitatory transcutaneous spinal cord stimulation: The training session for the experimental group comprises of activity-based therapy along with facilitatory stimulation on the spinal cord of the participants. These training sessions will include repetitive, intensive strength training and functional exercises targeting arm and hand (upper limb) movements. Sessions will be delivered by trained physiotherapists and occupational therapists. Each participant will complete 20 sessions over six to eight weeks (three per week), with each session lasting 45 minutes. Breaks will be added, if needed. Training will consist of cardiovascular training, stretching, weight-bearing, strengthening and controlled strengthening and task-oriented training. Participants will receive transcutaneous spinal cord stimulation set at a target intensity that facilitates voluntary upper limb movement (usually between 10 and 25 mA) in the participants.

Study summary

The goal of this RCT study is to evaluate if combining activity-based therapy (ABT) with transcutaneous spinal cord stimulation (tSCS) can improve recovery of arm and hand movement in people with cervical spinal cord injury (SCI). As secondary aims, the study will also investigate at how this combination approach affects the cortical changes in the somatosensory and motor areas of the brain, as well as in the spinal cord and whether it helps participants use their arms more in daily life.

The main questions relevant to this study are:

1. Can the combination of ABT + tSCS improve motor and sensory functions of the arms and hands more than ABT alone during the sub-acute stage after SCI?
2. Does ABT + tSCS induce neuroplasticity, that is, changes in the brain and spinal cord activity linked to motor and sensory functions?
3. Do participants who receive ABT + tSCS report greater use of their arms in daily activities compared to those who receive ABT only?

In this study, participants will:

* Receive either ABT + tSCS or ABT + sham stimulation (a low-intensity current that does not facilitate the movements)
* Take part in 20 training sessions over 6-8 weeks (3 times per week, 45 min of active training each). During this, they will perform strengthening, task-based training, and motor control strengthening exercises with a therapist.
* Complete clinical tests and neurophysiological assessments (transspinal electrical stimulation, electroencephalography and transcranial magnetic stimulation) at three time points-- at the start, after training, and one month later to measure recovery and brain activity changes.

Researchers will compare the assessment outcomes across the three time points.

Eligibility

Sex
ALL
Min age
16 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Traumatic and non-traumatic spinal cord injury * Receiving in-patient rehabilitation * 16 years old or above * American Spinal Injury Association (ASIA) grade A to D * Neurological injury level between C5 and T2 * Residual upper limb motor impairments Exclusion Criteria: * Cardiac pacemaker * Active cancer at the stimulation site or metastatic cancer * Unstable lesion or clinical condition (e.g. respiratory issues) * Electrode placement is impossible due to unhealed wound or significant local pain * Other Neurological condition (e.g. Stroke, Parkinson's) * Chronic liver or kidney disease * Uncontrolled psychiatric condition * Life expectancy \< 6 months * Inability to provide informed consent (i.e., severe cognitive impairment, dementia, or Alzheimer's disease)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Institut de réadaptation Gingras-Lindsay-de-Montréal (IRGLM) Montreal Quebec

More Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07361627 on ClinicalTrials.gov ↗ ← All trials in Canada